|
Other issues |
Opinion
Much to consider on the future of warfarinS Millen and D McRobbie
CP 2011;3:264
Editor’s choice
Stepping up surveillance
M Wright
CP 2011;3:226
Update
Doubts over statin link with intracerebral haemorrhage
CP 2011;3:267
Leadership competency framework launched
CP 2011;3:267
NSAIDS may increase risk of miscarriage
CP 2011;3:267
Tobramycin inhaler for patients with cystic fibrosis now available
CP 2011;3:267
Call for post-nominals for pharmacist prescribers
CP 2011;3:267
Adjuvant zoledronic acid does not improve survival for early breast cancer
CP 2011;3:267
CP 2011;3:268
Debate over antimuscarinic drugs and cognitive decline continues
CP 2011;3:268
News feature
Teamwork receives a boost at the RPS Conference
K Towers and M Wright
CP 2011;3:270
Columnist
Reflections of an independent prescriber
New ways to tackle non-attendance
P Forsyth
CP 2011;3:272
Clinical focus
Intravenous fluids: principles of treatment
K Floss, M Borthwick and C Clark
CP 2011;3:274
Intravenous fluids: practical aspects of therapy
J Dade, A Staples and C Acomb
CP 2011;3:285
Lifelong Learning (Intravenous fluids)
CP 2011;3:293
Practice tools
How to screen people for possible depression
D Taylor, J Donoghue and R Hall
CP 2011;3:294
Innovation and collaboration
Improving local compliance with standards for oxygen prescribing
G Nickless and R Fallon
CP 2011;3:299
Pipeline
October 2011
CP 2011;3:303
Spotlight on medicines
Fingolimod
C Herring
CP 2011;3:306
FAQ
How should ankle oedema caused by calcium channel blockers be treated?
CP 2011;3:308
In the clinic
Multidisciplinary approach helps patients to manage chronic pain
R Larkin
CP 2011;3:309
Clinical Pharmacist